Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Equinor ADR | EQNR | Mar 14, 2025 | 24.29 | +2.14 |
Equinox Gold | EQX | Mar 14, 2025 | 6.74 | -0.59 |
Equitable A Pref | EQH-A | Mar 14, 2025 | 20.91 | +0.19 |
Equitable C Pref | EQH-C | Mar 14, 2025 | 17.72 | +1.26 |
Equitable Holdings | EQH | Mar 14, 2025 | 51.27 | +3.49 |
Equity Bancshares A | EQBK | Mar 14, 2025 | 39.92 | +2.28 |
Equity Commonwealth | EQC | Mar 14, 2025 | 1.60 | +0.63 |
Equity Income Wisdomtree | DHS | Mar 14, 2025 | 97.26 | +1.11 |
Equity Lifestyle Properties | ELS | Mar 14, 2025 | 67.05 | +1.54 |
Equity Residential | EQR | Mar 14, 2025 | 68.94 | +0.97 |
Equus Total Return | EQS | Mar 14, 2025 | 1.05 | -6.82 |
EQV Ventures Acquisition | EQV | Mar 14, 2025 | 10.04 | -0.10 |
Erasca | ERAS | Mar 14, 2025 | 1.44 | -2.04 |
Erayak Power Solution Group A | RAYA | Mar 14, 2025 | 1.22 | -1.48 |
Ericsson B ADR | ERIC | Mar 14, 2025 | 8.20 | +3.80 |
Erie Indemnity A | ERIE | Mar 14, 2025 | 421.53 | +0.78 |
Ermenegildo Zegna N.V. | ZGN | Mar 14, 2025 | 7.32 | +1.95 |
Ero Copper | ERO | Mar 14, 2025 | 12.63 | +1.53 |
ESAB | ESAB | Mar 14, 2025 | 120.28 | +3.77 |
Escalade | ESCA | Mar 14, 2025 | 15.03 | +1.83 |
Esco Technologies | ESE | Mar 14, 2025 | 160.93 | +2.60 |
ESGL | ESGL | Mar 14, 2025 | 2.03 | +7.36 |
ESH Acquisition | ESHA | Mar 14, 2025 | 10.77 | +0.09 |
Eshallgo | EHGO | Mar 14, 2025 | 1.04 | -2.70 |
Esperion Therapeutics | ESPR | Mar 14, 2025 | 1.50 | 0.00 |
Espey Mfg & Electronics | ESP | Mar 14, 2025 | 26.95 | +1.59 |
Esquire Financial | ESQ | Mar 14, 2025 | 73.10 | +2.44 |
ESS Tech | GWH | Mar 14, 2025 | 3.25 | +1.25 |
ESSA Bancorp | ESSA | Mar 14, 2025 | 19.30 | +1.79 |
ESSA Pharma | EPIX | Mar 14, 2025 | 1.62 | -0.61 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.